Moral decision-making has long fascinated psychologists because it pits two competing systems against each other: a cold, calculating tendency to maximize outcomes (the utilitarian response) and a hot, emotionally driven resistance to directly causing harm to another person (the deontological response). In the canonical trolley problem, most people say it is permissible to divert a runaway trolley to kill one person instead of five—a utilitarian choice made at a distance, where harm is an incidental side effect. Yet most of those same people refuse the equivalent choice in the footbridge variant, where one person must be physically pushed to their death—harm used as an instrument to achieve the goal. Neuroimaging work by Joshua Greene and colleagues, published in Science in 2001, showed that these “personal,” high-conflict dilemmas engage emotional and social brain regions more strongly, suggesting that emotional aversion to up-close harm drives the refusal to sacrifice one to save many.

Whether autistic people show this same profile has been debated for decades. Early theoretical accounts proposed that autism involves impairments in empathy and Theory of Mind (ToM)—the capacity to attribute mental states such as beliefs and intentions to others—which might blunt the emotional aversion to harm and produce more utilitarian, even coldly calculating judgments. Some studies reported exactly that, fueling a persistent and harmful stereotype that autistic people lack moral feeling. More recent systematic reviews, including work by Dempsey and colleagues, have suggested that basic moral judgment is largely intact in autism, though findings remain mixed and the literature suffers from small samples and inconsistent methods. The new Italian study adds an unusually detailed data point to this debate by manipulating two specific features of moral dilemmas: whether the harm is incidental or instrumental, and whether the decision-maker is personally at risk.

The researchers recruited twenty autistic adolescents and adults (mean age 21.60, standard deviation 8.10, with a mean of 12.40 years of education) and twenty-nine neurotypical participants (mean age 22.28, standard deviation 2.8, with 14.38 years of education). Autistic participants were assessed using the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2). All participants read a battery of moral dilemmas drawn from validated Italian normed sets and rated the moral acceptability of utilitarian courses of action. The dilemma set systematically varied along two dimensions: incidental dilemmas, in which harm befalls someone as a side effect of an action that produces a greater good, versus instrumental dilemmas, in which harm to the victim is the means by which the good outcome is achieved; and dilemmas in which the protagonist’s own life was at stake versus those in which only others’ lives were threatened.

To examine individual differences that might underpin moral choices, participants also completed measures of empathy (the Empathy Quotient), advanced Theory of Mind, and Machiavellianism—a personality construct characterized by cynicism, strategic manipulation and emotional detachment, classically measured with instruments derived from the Christie and Geis Mach-IV scale. The researchers then analyzed the data using mixed-design repeated-measures ANOVAs, a statistical approach that allows within-subject factors (dilemma type and personal risk) to be evaluated alongside the between-subjects factor of group membership. Exploratory correlation analyses were conducted to see how ToM, empathy and Machiavellianism related to utilitarian responding within each group.

The headline finding was one of similarity. Both groups showed the classic signature of moral cognition: significantly higher acceptability ratings for utilitarian actions in incidental dilemmas than in instrumental ones, and a drop in utilitarian choices when harm became the instrument of salvation. In other words, autistic participants, like neurotypical ones, found it more acceptable to let harm happen as a side effect than to use a person as a means to an end—a pattern consistent with the deontological constraints documented across the general population. The authors emphasize that overall moral outcomes in the autistic group were “broadly comparable” to those of the neurotypical group, a result that directly counters lingering assumptions of moral deficit in autism.

But the fine structure of the data revealed group differences. The reduction in utilitarian responding from incidental to instrumental dilemmas, while present in both groups, was less pronounced among autistic participants. More strikingly, personal risk involvement shifted judgments in opposite ways: neurotypical participants became more utilitarian when their own lives were on the line, whereas personal risk did not significantly influence the choices of autistic participants. This suggests that the self-preservation calculus that tilts neurotypical moral judgment toward sacrifice of others may operate differently—or be integrated differently—when the decision-maker is autistic.

On the social cognition measures, the autistic group reported lower empathy and lower Theory of Mind abilities than the neurotypical group, replicating well-established group differences. Yet Machiavellianism scores did not differ between groups—a result with real significance for the stereotype question. If autistic moral reasoning were driven by cold, manipulative indifference, one would expect elevated Machiavellianism; instead, the groups were indistinguishable on this trait, indicating that any differences in utilitarian responding cannot be attributed to darker personality dispositions.

The exploratory correlations added a further layer of nuance. Rather than showing uniform relationships across the board, the analyses suggested that ToM and Machiavellianism related to utilitarian choices only in specific dilemma conditions, and in group-specific ways: relationships between these social cognitive measures and utilitarian responding emerged within each group, but tied to different dilemma contexts. The authors interpret this as evidence that autistic and neurotypical individuals may integrate information about harm intentionality, personal involvement and normative constraints through partly different cognitive routes, even when the endpoints of their decisions look alike.

The study’s methodological approach deserves attention. By crossing the incidental/instrumental distinction with personal risk, the design separates two factors that are usually confounded in the trolley-and-footbridge paradigm. The incidental versus instrumental manipulation isolates the role of intentionality—whether harm is foreseen or intended—while the personal risk manipulation isolates self-interest, a factor shown in prior work to increase utilitarian responding in the general population. The finding that these two factors behave differently in autism provides a more precise picture than a simple “autistic people are more utilitarian” headline could offer. It also aligns with a growing literature suggesting that alexithymia—difficulty identifying and describing one’s own emotions—rather than autism itself may explain atypical moral judgments in some autistic individuals, as Patil and colleagues reported in Scientific Reports in 2016.

The authors are careful to frame their conclusions within the limits of an exploratory design. The sample was modest in size, with unequal group numbers, and the correlation analyses were explicitly exploratory rather than confirmatory, meaning they generate hypotheses rather than establish robust effects. Education levels also differed slightly between groups, and the autistic group showed greater age variability. These constraints temper strong generalizations. Nevertheless, the convergent picture—intact core moral judgment, intact aversion to instrumental harm, reduced sensitivity to personal risk, and no elevation in Machiavellianism—adds to a mounting body of evidence that the moral minds of autistic people are not deficient, merely differently calibrated.

Why might personal risk fail to boost utilitarian responding in autism? The authors suggest that context-dependent patterns may reflect differences in how personal involvement and normative constraints are integrated into the decision process. One possibility is that neurotypical self-interest operates through emotional and interoceptive signals—visceral fear, anticipated regret—which may register differently in autistic cognition, a question increasingly studied through the lens of interoception and alexithymia in autism research. Another possibility relates to rule-based reasoning: if autistic participants anchor judgments more firmly in explicit moral rules than in self-serving emotional pulls, their choices would remain stable regardless of whether their own survival is at stake. The study cannot adjudicate between these accounts, but it sets up clear hypotheses for future work with larger samples and, potentially, virtual reality paradigms that make dilemma contexts more immersive, as recent reviews of moral dilemma methodology have proposed.

The findings also carry practical implications. Clinicians and educators sometimes encounter assumptions that autistic young people struggle with moral reasoning, which can affect how social conflicts involving autistic individuals are interpreted. This study suggests that when an autistic person endorses a utilitarian solution to a dilemma, or declines to shift their judgment under self-preservative pressure, this reflects a different integration of contextual information rather than a lack of moral feeling or an excess of cunning. Given that Machiavellianism did not differ between groups, the research offers no support for the harmful trope of the “calculating” autistic mind.

In the broader landscape of moral psychology, the study contributes to a reframing that has been gathering momentum: moral judgment differences across neurotypes are best understood not as deficits but as variations in how intention, causality, emotion and self-interest are weighted. As the authors conclude, moral decision-making in autistic individuals was broadly comparable to that of neurotypical individuals in overall outcomes, while the context-dependent patterns they observed point to meaningful differences in the underlying architecture of moral cognition. For a field still working to disentangle autism from its stereotypes, that is a finding worth pushing a trolley for.

Oxytocin, often referred to as the “love hormone,” is a peptide produced in the hypothalamus and released into the bloodstream by the posterior pituitary. While traditionally recognized for its role in reproductive behaviors, such as childbirth and lactation, recent studies have elucidated its broader social functions, including the facilitation of social recognition and attachment. This has led researchers to explore how oxytocin levels may differ in individuals with autism, who frequently exhibit challenges in social interaction and communication.

A comprehensive overview by Lal et al. delves into how oxytocin may serve as a key modulator of social behavior in individuals with ASD. Evidence suggests that individuals with autism may have dysregulated oxytocin signaling. This dysregulation may contribute to difficulties in forming social connections and understanding social cues. By exploring the neurobiological pathways influenced by oxytocin, researchers aim to identify potential interventions that could ameliorate the social deficits commonly associated with ASD.

The mechanisms by which oxytocin influences behavior are complex and multifaceted. For instance, oxytocin receptors are widely distributed throughout the brain, particularly in regions involved in social processing, such as the amygdala and prefrontal cortex. In these areas, oxytocin is thought to enhance emotional recognition and responsiveness, aiding individuals in developing empathic understanding. These insights have prompted researchers to consider oxytocin administration as a possible treatment avenue, although efficacy and safety remain areas of active investigation.

Recent trials have attempted to assess whether oxytocin nasal spray can improve social functioning in individuals with ASD. Initial findings show promise, with participants exhibiting improved social responsiveness and decreased anxiety during social interactions. However, the results have been mixed, prompting an ongoing debate about the consistency of oxytocin’s effects and the need for further research to clarify its potential role as a therapeutic agent. There remains a reservoir of skepticism, with some experts pointing to the complexities of oxytocin’s action in the human brain.

Additionally, genetic factors may play a crucial role in how individuals respond to oxytocin treatment. Variations in the gene encoding the oxytocin receptor could predict the degree of behavioral change in response to oxytocin administration. Understanding these genetic factors may not only guide personalized approaches to treatment but also enhance our understanding of the neurobiology underlying social behavior in ASD.

Lal et al. also emphasize the importance of environmental influences on oxytocin levels. For example, social experiences, bonding activities, and even physical touch can modulate oxytocin release. This interaction suggests that environmental interventions—such as family therapy or structured social skills training—could complement pharmacological approaches, enhancing the therapeutic landscape for individuals with ASD.

Another intriguing aspect of the research is the intersection of oxytocin with other neuropeptides and neurotransmitter systems. For example, studies indicate that oxytocin interacts with dopamine pathways, which are known to influence motivation and reward processing. This presents exciting opportunities for developing multidisciplinary treatment strategies that harness the synergistic effects of various neurobiological systems.

As the exploration of oxytocin in relation to ASD evolves, it highlights the need for rigorous scientific inquiry to unravel this hormone’s nuances. Researchers advocate for larger, well-controlled clinical trials to validate small-scale findings, focusing on robust measures of social functioning and quality of life improvements. These endeavors will ultimately contribute to a more profound understanding of how integrative mechanisms of oxytocin might be leveraged for therapeutic gains in clinical populations.

In summary, the overview presented by Lal et al. sheds light on the exciting and emergent field of oxytocin research in autism spectrum disorder. By elucidating the intricacies of oxytocin’s integrative mechanisms, the study opens a pathway for potential innovations in treatment. Although the journey from bench to bedside remains fraught with challenges, the hope is that, through collaborative research efforts, we may eventually unravel the therapeutic potential of this remarkable neuropeptide.

As researchers continue to decode the complex roles of oxytocin in the human brain, it is evident that understanding its integrative mechanisms is crucial for developing effective strategies for ASD. The road ahead is paved with opportunities, as each discovery brings us closer to a future where individuals with autism can experience improved social interactions and emotional well-being. The confluence of neurobiology, genetics, and environmental influences provides a rich tapestry for ongoing research, promising a more nuanced approach to autism intervention strategies. Ultimately, the implications of these findings reach far beyond the realm of autism, offering insights into human social behavior and the neurochemical foundations of connection and empathy.

With the groundwork being laid, the future of oxytocin research appears bright. The hope is that continued investigation will yield actionable insights that benefit individuals with ASD, enhancing their quality of life and fostering deeper connections within their communities. In this era of neuroscience, where complex mental health challenges demand nuanced solutions, the study of oxytocin stands at the forefront, promising to unlock new doors in our understanding and treatment of autism spectrum disorder.

Subject of Research: Autism spectrum disorder and the role of oxytocin in social behavior.

Article Title: An overview of oxytocin integrative mechanisms in autism spectrum disorder.

Article References:

Lal, N., Song, B., Zhang, C. et al. An overview of oxytocin integrative mechanisms in autism spectrum disorder.
Discov Ment Health 5, 185 (2025). https://doi.org/10.1007/s44192-025-00331-1

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s44192-025-00331-1

Keywords: Autism spectrum disorder, Oxytocin, Social behavior, Therapeutic potential, Neurobiology.